Comparison of pre-treatment with OCPs or estradiol valerate vs. no pre-treatment prior to GnRH antagonist used for IVF cycles: An RCT

BACKGROUND: Both oral contraceptive pills (OCPs) and estradiol valerate (E2) have been used to schedule a gonadotropin-releasing hormone antagonist in vitro fertilization (IVF) cycles. Since the suppression of follicle-stimulating hormone by OCPs can stay 5-7 days after stopping the pills, it seems...

Descripción completa

Detalles Bibliográficos
Autores principales: Shahrokh Tehrani Nejad, Ensieh, Bakhtiari Ghaleh, Fatemeh, Eslami, Bita, Haghollahi, Fedyeh, Bagheri, Maryam, Masoumi, Masoumeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research and Clinical Center for Infertility 2018
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163045/
https://www.ncbi.nlm.nih.gov/pubmed/30288488

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163045/
https://www.ncbi.nlm.nih.gov/pubmed/30288488

Ejemplares similares